ANPEP and cancer: Hence, the characterization of the distinctive glycostructure and substrate specificity of cancer-specific CD13 glycoforms could enable the development of highly specific CD13 antibody and peptide substrate for potent ADCs and PDCs that target only cancer-expressed CD13 glycoforms.47